NO965109D0 - Antimicrobial compositions - Google Patents

Antimicrobial compositions

Info

Publication number
NO965109D0
NO965109D0 NO965109A NO965109A NO965109D0 NO 965109 D0 NO965109 D0 NO 965109D0 NO 965109 A NO965109 A NO 965109A NO 965109 A NO965109 A NO 965109A NO 965109 D0 NO965109 D0 NO 965109D0
Authority
NO
Norway
Prior art keywords
antimicrobial compositions
antimicrobial
compositions
Prior art date
Application number
NO965109A
Other languages
Norwegian (no)
Inventor
Zvi Malik
Yeshayahua Nitzan
Original Assignee
Univ Bar Ilan
Lichtenstein Joseph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL10987494A external-priority patent/IL109874A0/en
Priority claimed from IL10987594A external-priority patent/IL109875A0/en
Priority claimed from IL10987694A external-priority patent/IL109876A0/en
Application filed by Univ Bar Ilan, Lichtenstein Joseph filed Critical Univ Bar Ilan
Publication of NO965109D0 publication Critical patent/NO965109D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO965109A 1994-06-02 1996-11-29 Antimicrobial compositions NO965109D0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL10987494A IL109874A0 (en) 1994-06-02 1994-06-02 Synergistic antimicrobial compositions
IL10987594A IL109875A0 (en) 1994-06-02 1994-06-02 Antimicrobial cream compositions
IL10987694A IL109876A0 (en) 1994-06-02 1994-06-02 Antimicrobial liquid compositions
PCT/US1995/006998 WO1995033463A2 (en) 1994-06-02 1995-05-30 Synergistic antibiotic compositions containing a perphyrin and an antibiotic

Publications (1)

Publication Number Publication Date
NO965109D0 true NO965109D0 (en) 1996-11-29

Family

ID=27271659

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965109A NO965109D0 (en) 1994-06-02 1996-11-29 Antimicrobial compositions

Country Status (5)

Country Link
EP (1) EP0765161A2 (en)
AU (1) AU2816195A (en)
CA (1) CA2191627A1 (en)
NO (1) NO965109D0 (en)
WO (1) WO1995033463A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620805B1 (en) 1996-03-14 2003-09-16 Yale University Delivery of nucleic acids by porphyrins
NL1020336C2 (en) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Use of a compound for the preparation of a pharmaceutical preparation for treating burns, and a method for treating burns.
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
CN113425850B (en) * 2021-06-04 2022-10-11 江南大学 Photosensitive antibacterial modified porphyrin metal organic framework material and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU721442A1 (en) * 1977-09-12 1980-03-15 Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им. М.В. Ломоносова Method of preparing beta-unsubstituted porphyrins
JPS58981A (en) * 1981-06-26 1983-01-06 Tama Seikagaku Kk Water-soluble porphyrin derivative
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
JPS61189284A (en) * 1985-02-18 1986-08-22 Tama Seikagaku Kk Water-soluble porphyrin derivative metal chelate compound
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
FR2683724A1 (en) * 1991-11-15 1993-05-21 Agronomique Inst Nat Rech BACTERICIDE PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND FOOD ADDITIVE.
US5611793A (en) * 1992-04-30 1997-03-18 Institute Of Dental Surgery Laser treatment
AU1296795A (en) * 1993-12-28 1995-07-17 New York Blood Center, Inc., The Methods for preventing or treating hiv-1 or hiv-2 infection

Also Published As

Publication number Publication date
WO1995033463A3 (en) 1996-05-17
WO1995033463A2 (en) 1995-12-14
AU2816195A (en) 1996-01-04
CA2191627A1 (en) 1995-12-14
EP0765161A2 (en) 1997-04-02

Similar Documents

Publication Publication Date Title
DE69526966D1 (en) SKIN-STRENGTHING COMETIC COMPOSITION
FI103751B1 (en) Antimicrobial compositions
DE69722930D1 (en) PESTICIDAL COMPOSITIONS
DE69520639D1 (en) Disinfectant composition
BR9408582A (en) Herbicidal composition
DE69618953D1 (en) MICROBICIDAL COMPOSITIONS
DE69626556D1 (en) Biocidal compositions
BR9509374A (en) Herbicidal compositions
DE69708866D1 (en) MICRO-ENCLOSED COMPOSITIONS
FI954773A0 (en) Anti-hypertriglyceridemia composition
ATE293672T1 (en) COLOR-FRIENDLY COMPOSITIONS
DE69613060D1 (en) Synergistic fungicidal compositions
FI962574A (en) Microbicidal composition
BR9508191A (en) Herbicidal composition
DE69510157D1 (en) Synergistic insecticidal compositions
FI972421A0 (en) Antioxidant compositions
ITMI940362A0 (en) ANTICOUGH COMPOSITION
BR9711977A (en) Biocidal compositions
FI963631A0 (en) Insecticidal compositions
ATE186448T1 (en) MICROBICIDAL COMPOSITION
BR9509287A (en) Microbicidal compositions
MA23731A1 (en) DETEGENT COMPOSITIONS
BR9503633A (en) Disinfectant composition
NO980595D0 (en) Biocidal compositions
EE03731B1 (en) Synergistic fungicidal compositions